Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.

作者: Simona D’Aguanno , Elisabetta Valentini , Maria Grazia Tupone , Marianna Desideri , Marta Di Martile

DOI: 10.1186/S13046-018-0933-X

关键词: MelanomaTranscription factorCell migrationMetastasisCancer researchSemaphorinBiologyBlotApoptosisChromatin immunoprecipitation

摘要: Melanoma, the most aggressive form of skin cancer, is characterized by high rates metastasis, drug resistance and mortality. Here we investigated role Semaphorin 5A (Sema5A) on properties associated with melanoma progression factors involved in Sema5A regulation. Western blotting, qRT-PCR, Chromatin immunoprecipitation (ChIP) assay, immunohistochemistry patient specimens xenograft tissues, vitro Transwell assay for cell migration invasion evaluation, capillary-like structure formation analysis. A significant correlation mRNA expression was observed analyzing GEO profile dataset. Endogenous protein detected 95% human lines tested, 70% metastatic from patients affected melanoma, 16% situ melanoma showed a focal positivity. We demonstrated that regulates vasculogenic structures. also found an increase at both level after forced Bcl-2. By use transcriptional proteasome inhibitors, Bcl-2 increases stability protein. Moreover, ChIP under control transcription factor c-Myb recruitment promoter increased overexpression. Finally, concomitant decrease Sema5A, proteins cells miR-204 Overall our data provide evidences supporting involvement Bcl-2, regulating its expression.

参考文章(56)
Ludovica Ciuffreda, Donatella Del Bufalo, Marianna Desideri, Cristina Di Sanza, Antonella Stoppacciaro, Maria Rosaria Ricciardi, Sabina Chiaretti, Simona Tavolaro, Barbara Benassi, Alfonso Bellacosa, Robin Foà, Agostino Tafuri, Francesco Cognetti, Andrea Anichini, Gabriella Zupi, Michele Milella, Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations. Neoplasia. ,vol. 11, pp. 720- 731 ,(2009) , 10.1593/NEO.09398
Daniela Trisciuoglio, Teresa De Luca, Marianna Desideri, Daniela Passeri, Chiara Gabellini, Stefania Scarpino, Chengyu Liang, Augusto Orlandi, Donatella Del Bufalo, Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth. Neoplasia. ,vol. 15, pp. 315- 327 ,(2013) , 10.1593/NEO.121392
Rossella Loria, Giulia Bon, Valentina Perotti, Enzo Gallo, Ilaria Bersani, Paola Baldassari, Manuela Porru, Carlo Leonetti, Selene Di Carlo, Paolo Visca, Maria Felice Brizzi, Andrea Anichini, Roberta Mortarini, Rita Falcioni, Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells. Oncotarget. ,vol. 6, pp. 2779- 2793 ,(2015) , 10.18632/ONCOTARGET.2995
Aleksandra Butrym, Justyna Rybka, Dagmara Baczyńska, Andrzej Tukiendorf, Kazimierz Kuliczkowski, Grzegorz Mazur, Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients. Journal of Experimental & Clinical Cancer Research. ,vol. 34, pp. 68- 68 ,(2015) , 10.1186/S13046-015-0184-Z
Daniela Trisciuoglio, Marianna Desideri, Ludovica Ciuffreda, Marcella Mottolese, Domenico Ribatti, Angelo Vacca, Mario Del Rosso, Lucia Marcocci, Gabriella Zupi, Donatella Del Bufalo, Bcl‐2 overexpression in melanoma cells increases tumor progression‐associated properties and in vivo tumor growth Journal of Cellular Physiology. ,vol. 205, pp. 414- 421 ,(2005) , 10.1002/JCP.20413
Goutam Chakraborty, Santosh Kumar, Rosalin Mishra, Tushar V. Patil, Gopal C. Kundu, Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model. PLOS ONE. ,vol. 7, ,(2012) , 10.1371/JOURNAL.PONE.0033633
A Sacconi, F Biagioni, V Canu, F Mori, A Di Benedetto, L Lorenzon, C Ercolani, S Di Agostino, A M Cambria, S Germoni, G Grasso, R Blandino, V Panebianco, V Ziparo, O Federici, P Muti, S Strano, F Carboni, M Mottolese, M Diodoro, E Pescarmona, A Garofalo, G Blandino, miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer Cell Death and Disease. ,vol. 3, ,(2012) , 10.1038/CDDIS.2012.160
Michelandrea De Cesare, Paola Perego, Sabina C. Righetti, Graziella Pratesi, Nives Carenini, Licia Rivoltini, Gabriella Zupi, Donatella Del Bufalo, Andrea Balsari, Franco Zunino, Enhanced antitumour efficacy of gimatecan in combination with Bcl-2 antisense oligonucleotide in human melanoma xenografts. European Journal of Cancer. ,vol. 41, pp. 1213- 1222 ,(2005) , 10.1016/J.EJCA.2005.03.001
Il-Hoan Oh, E Premkumar Reddy, The myb gene family in cell growth, differentiation and apoptosis. Oncogene. ,vol. 18, pp. 3017- 3033 ,(1999) , 10.1038/SJ.ONC.1202839
Guoqing Pan, Hui Lv, Hongzheng Ren, Ying Wang, Ying Liu, Haiying Jiang, Jifang Wen, Elevated expression of semaphorin 5A in human gastric cancer and its implication in carcinogenesis Life Sciences. ,vol. 86, pp. 139- 144 ,(2010) , 10.1016/J.LFS.2009.12.004